bupivacaine has been researched along with apelin-13 peptide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cai, Y; Chen, H; Jin, Z; Liu, L; Papadimos, TJ; Shi, K; Wang, Q; Xia, E; Xia, F; Xia, Y; Xu, X; Ye, Y | 1 |
1 other study(ies) available for bupivacaine and apelin-13 peptide
Article | Year |
---|---|
Apelin-13 Reverses Bupivacaine-Induced Cardiotoxicity via the Adenosine Monophosphate-Activated Protein Kinase Pathway.
Topics: AMP-Activated Protein Kinases; Animals; Bupivacaine; Cardiotoxicity; Cell Line; Disease Models, Animal; DNA Damage; Heart Diseases; Intercellular Signaling Peptides and Proteins; Male; Mitochondria, Heart; Myocytes, Cardiac; Oxidative Stress; Phosphatidylinositol 3-Kinase; Rats, Sprague-Dawley; Signal Transduction | 2021 |